The staked ETF assets are getting closer and closer. Do you all remember when ETH had its ETF? At that time, it was still before the Trump era, and the SEC instructed that staking features should be excluded as a condition for approving the ETF, which is why the current ETH ETFs are launched without staking features. Initially, I thought this might delay institutions from purchasing ETH, but ultimately, with the onset of the bull market, institutions are currently buying ETH ETFs in huge amounts even without staking. In this regard, $INJ is making strides in various areas with the motto of being a blockchain for finance. To foster relationships with institutions, it is expanding by building connections here and there in New York, and during the time when the dApp ecosystem was stagnant, it is gradually creating opportunities for many projects to onboard by introducing MultiVM. Additionally, CBOE has applied to the SEC for the Canary Capital Staked $INJ ETF, which means that @injective is preparing to apply for an ETF based on already staked INJ and sell it to institutions. Currently, the buying pressure for INJ is not that high, but if an ETF is offered with a staking interest rate of 12%, which is higher than Ethereum's staking rate (which is at most 4-5% even when staked), we might see whether institutions will have a strong demand for staking interest despite the higher risk compared to ETH. This has a flywheel effect; as institutional demand increases, the staking interest rate will likely decrease. Moreover, as more INJ is staked, the amount of INJ available in the market will also decrease. This phenomenon could potentially raise the demand for LST and LRT tokens within Injective.